- Home
- ARCT vs CUB Comparison
ARCT vs CUB Comparison
Compare ARCT & CUB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ARCT
- CUB
- Stock Information
- Founded
- ARCT 2013
- CUB 2024
- Country
- ARCT United States
- CUB United States
- Employees
- ARCT N/A
- CUB N/A
- Industry
- ARCT Biotechnology: Pharmaceutical Preparations
- CUB
- Sector
- ARCT Health Care
- CUB
- Exchange
- ARCT Nasdaq
- CUB NYSE
- Market Cap
- ARCT 298.3M
- CUB 320.5M
- IPO Year
- ARCT N/A
- CUB 2024
- Fundamental
- Price
- ARCT $12.10
- CUB $10.54
- Analyst Decision
- ARCT Strong Buy
- CUB
- Analyst Count
- ARCT 8
- CUB 0
- Target Price
- ARCT $52.33
- CUB N/A
- AVG Volume (30 Days)
- ARCT 484.3K
- CUB 95.7K
- Earning Date
- ARCT 08-04-2025
- CUB 05-13-2025
- Dividend Yield
- ARCT N/A
- CUB N/A
- EPS Growth
- ARCT N/A
- CUB N/A
- EPS
- ARCT N/A
- CUB 0.34
- Revenue
- ARCT $143,680,000.00
- CUB N/A
- Revenue This Year
- ARCT N/A
- CUB N/A
- Revenue Next Year
- ARCT $39.32
- CUB N/A
- P/E Ratio
- ARCT N/A
- CUB $31.34
- Revenue Growth
- ARCT 15.38
- CUB N/A
- 52 Week Low
- ARCT $8.04
- CUB $9.96
- 52 Week High
- ARCT $45.00
- CUB $10.55
- Technical
- Relative Strength Index (RSI)
- ARCT 48.75
- CUB N/A
- Support Level
- ARCT $11.51
- CUB N/A
- Resistance Level
- ARCT $13.27
- CUB N/A
- Average True Range (ATR)
- ARCT 0.82
- CUB 0.00
- MACD
- ARCT 0.01
- CUB 0.00
- Stochastic Oscillator
- ARCT 26.15
- CUB 0.00
About ARCT Arcturus Therapeutics Holdings Inc.
Arcturus Therapeutics Holdings Inc is an RNA medicines company focused on opportunities in rare diseases with a current focus on liver and respiratory diseases. It operates in one business segment, which includes all activities related to the discovery, development and commercialization of messenger RNA medicines. The company's pipeline includes LUNAR-OTC, LUNAR-CF, LUNAR-FLU, and LUNAR-COV19.
About CUB LIONHEART HOLDINGS
Lionheart Holdings is a blank check company.